# Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY)

> **NCT02859038** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Shanghai Gynecologic Oncology Group** · enrollment: 489 (actual)

## Conditions studied

- Epithelial Ovarian Cancer
- Fallopian Tube Cancer
- Primary Peritoneal Carcinoma

## Interventions

- **PROCEDURE:** Upfront cytoreductive surgery
- **PROCEDURE:** Interval debulking surgery

## Key facts

- **NCT ID:** NCT02859038
- **Lead sponsor:** Shanghai Gynecologic Oncology Group
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-08
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 489 (ACTUAL)
- **Last updated:** 2025-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02859038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02859038, "Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY)". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT02859038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*